[ad_1]
“Things are starting to get worse.” After the publication of today’s newsletter of the Ministry of Health is the renowned virologist Roberto Burioni the first to focus attention on the progress of the coronavirus epidemic in Italy, which took the form of the second wave.
“Please be careful, keep your distance, wear masks, avoid crowded places inside, wash your hands. The virus is out there, it is infectious and harmful as it was last spring -” write on twitter – Everything depends on us “
The bulletin that certifies the second wave: 24 deaths and 2,548 new cases
Today’s update confirms the worryingly rising trend in the number of new Sars-Cov-2 positivity cases that has brought the number of Covid patients over 52,000 to mid-May levels, but then the wave was decreasing. Today there are 2,548 new cases but with a record number of swabs, 118,236. 291 people hospitalized in intensive care (+11), more than 3 thousand hospitalized in the Covid wards. Unfortunately, 24 deaths are reported. The increase in infections in Veneto, more than 400 new cases, and Campania (+390), as well as in Lombardy (+324) is worrying. There is no immune region, but Valle d’Aosta and Molise have only one positive swab.
Just today, the Gimbe Foundation, in its usual independent follow-up, had highlighted some red lights confirming a more sustained circulation of the virus associated with a constant growth of hospitalized patients with symptoms and in intensive care. Data that allow us to glimpse the first critical problems in some regions: In particular, as of September 29, 6 Regions, almost the entire Center-South, registered hospitalization rates per 100,000 inhabitants higher than the national average.
“At Christmas 10 thousand Covid patients in hospitals, thousand serious”
If this linear growth of coronavirus cases in Italy were to continue on Christmas Eve, we would find 9-10 thousand covid patients in hospitals and a thousand in intensive care. “An absolutely manageable figure and nothing comparable to the figures for the February-March tsunami,” he explains. Nino Cartabellotta, president of the Foundation Gimbe then specifying: “It is clear that this very risky forecast can obviously be raised by unpredictable factors, as well as lowered by equally unpredictable factors. It is based only on the current speed of growth and the days that pass, therefore on two known variables and immutable “.
State of emergency: the extension to January 31
But what will happen to the second wave? So far the Government has ruled out the hypothesis of a second national closure, but as evidenced by the cases reported in recent days, there are many initiatives by local administrators that have increased the limitations on the territory of municipalities and regions.
In addition to the measures envisaged for the masks, which will also be carried outdoors, in the most difficult region, Campania, Governor De Luca has imposed a tough squeeze by limiting the possibility of organizing even private events.
De Luca threatens a new blockade
In other places, time limits have been imposed on public activities (prohibition of serving drinks except at the table and early closing at 10 p.m. for bars and restaurants), as well as limits on the possibility of consuming drinks and food in the air free.
The government is also evaluating extension of the state of emergency, for now set at October 15, which stands at January 31, 2021: the one-year milestone would be crossed, since exactly the January 31, 2020. During the meeting between Conte and the heads of the majority delegation, the need to promote the dissemination of Immune, the application to manage infection contact tracing. Hence the idea of a kind of television marathon, proposed by the Minister of Justice and Head of Delegation M5S Alfonso Bonafede, to convince and encourage Italians to download the application.
With the state of emergency they were foreseen exceptions for the widespread use of smart work, as well as an acceleration of the purchases of goods to face the pandemic (masks, gowns, benches on wheels, etc.) by the mission headed by Commissioner Domenico Arcuri to whom they are attributed special skills to face the pandemic.
The renewal of the state of emergency would expand the current rules that provide the obligation to wear a mask in closed places open to the public and outdoors from 6 to 6 hours in all those places where the formation of gatherings is easier, such as meeting places for nightlife. But it could allow, in case of growth of infections, to pass the obligation to wear the mask outdoors throughout the day.
Coronavirus, there is good news
Today, however, there is good news: the European drug agency has started the approval process for the Covid-19 vaccine developed by AstraZeneca and the University of Oxford, the first vaccine candidate to reach this stage. The ‘continuous review’, explains the EMA, is one of the regulatory tools implemented to speed up approval. Normally, all data is provided together at the beginning of the application for marketing authorization, whereas in this case the CHMP, the EMA committee in charge of the evaluation, reviews it as it becomes available, until it decides that it is. enough for one application. formal.
“The approval process for the AstraZeneca vaccine has started”
“The decision to initiate the continuous review of the vaccine is based on preliminary non-clinical results and on the first clinical trials,” says the statement, “which suggest that the vaccine stimulates the production of antibodies and T cells of the immune system that have the viruses like Large-scale clinical trials are being conducted in thousands of people, and the results will be available in the coming weeks and months. These will provide information on the efficacy of the vaccine in protecting against Covid-19, which will be evaluated in subsequent review cycles. “
Your browser cannot play the video.
You have to disable ad blocking to play the video.
stainCan not play video; Try it again later.
Wait a minute...
Maybe you might be interested...
You need to enable javascript to play the video.
The continuous review (used to expedite the evaluation of a promising drug or vaccine during a public health emergency) it will continue until sufficient evidence is available to support a formal application for marketing authorization.
[ad_2]
